Pretreatment Squamous Cell Carcinoma Antigen (SCC-Ag) as a Predictive Factor for the Use of Consolidation Chemotherapy in Cervical Cancer Patients After Postoperative Extended-Field Concurrent Chemoradiotherapy

Objective: The goal of this study was to confirm the clinical value of pretreatment serum squamous cell carcinoma antigen (SCC-Ag) in the administration of consolidation chemotherapy in patients with cervical cancers undergoing postoperative extended-field radiotherapy (EFRT) and concurrent chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Guangyu, Miao, Li, Wu, Haijian, Zhang, Youzhong, Fu, Chunli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493306/
https://www.ncbi.nlm.nih.gov/pubmed/34605696
http://dx.doi.org/10.1177/15330338211044626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493306/
https://www.ncbi.nlm.nih.gov/pubmed/34605696
http://dx.doi.org/10.1177/15330338211044626

Ejemplares similares